Skip to main content
×
Home

Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control

  • A. A. CHUGHTAI (a1), M. BARNES (a1) and C. R. MACINTYRE (a1)
Summary
SUMMARY

The aim of this study was to review the current evidence regarding the persistence of Ebola virus (EBOV) in various body fluids during convalescence and discuss its implication on disease transmission and control. We conducted a systematic review and searched articles from Medline and EMBASE using key words. We included studies that examined the persistence of EBOV in various body fluids during the convalescent phase. Twelve studies examined the persistence of EBOV in body fluids, with around 800 specimens tested in total. Available evidence suggests that EBOV can persist in some body fluids after clinical recovery and clearance of virus from the blood. EBOV has been isolated from semen, aqueous humor, urine and breast milk 82, 63, 26 and 15 days after onset of illness, respectively. Viral RNA has been detectable in semen (day 272), aqueous humor (day 63), sweat (day 40), urine (day 30), vaginal secretions (day 33), conjunctival fluid (day 22), faeces (day 19) and breast milk (day 17). Given high case fatality and uncertainties around the transmission characteristics, patients should be considered potentially infectious for a period of time after immediate clinical recovery. Patients and their immediate contacts should be informed about these risks. Convalescent patients may need to abstain from sex for at least 9 months or should use condoms until their semen tests are negative. Breastfeeding should be avoided during the convalescent phase. There is a need for more research on persistence, and a uniform approach to infection control guidelines in convalescence.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
*Author for correspondence: Dr A. A. Chughtai, Level 2, Samuels Building, School of Public Health & Community Medicine, UNSW Medicine, University of New South Wales, Sydney 2052, Australia (Email: abrar.chughtai@unsw.edu.au)
References
Hide All
1. World Health Organisation (WHO). Global alert and response (GAR). Ebola situation reports (http://www.who.int/csr/disease/ebola/situation-reports/en/). Accessed 5 October 2015.
2. Francesconi P, et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerging Infectious Diseases 2003; 9: 14301437.
3. MacIntyre CR, et al. Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations? International Journal of Nursing Studies 2014; 51: 14211426.
4. Rodriguez LL, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S170176.
5. Kreuels B, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. New England Journal of Medicine 2014; 371: 23942401.
6. Emond RT, et al. A case of Ebola virus infection. British Medical Journal 1977; 2: 541544.
7. Rowe AK, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S2835.
8. Bausch DG, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. Journal of Infectious Diseases 2007; 196 (Suppl. 2): S142147.
9. MacIntyre CR, Chughtai AA. Recurrence and reinfection with Ebola – a new paradigm. International Journal of Infectious Diseases (in press).
10. Richards GA, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Critical Care Medicine 2000; 28: 240244.
11. Lyon GM, et al. Clinical care of two patients with Ebola virus disease in the United States. New England Journal of Medicine 2014; 371: 24022409.
12. Ribner BS. Treating patients with Ebola virus infection in the U.S. Lessons learned at Emory University Hospital 2014 (https://www.uhc.edu/docs/5555-22-15801_EbolaLessonsLearned_presentationFINAL.pdf). Accessed 29 January 2015.
13. Moreau M, et al. Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Eurosurveillance 2015; 20.
14. Baggi FM, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Eurosurveillance 2014; 19.
15. Christie A, et al. Possible sexual transmission of Ebola virus – Liberia, 2015. Morbidity and Mortality Weekly Report 2015; 64: 479481.
16. Toweh A, Farge E. Liberia confirms new Ebola case as outbreak spreads (http://www.reuters.com/article/2015/07/14/us-health-ebola-idUSKCN0PO1EN20150714). Accessed 30 July 2015.
17. Varkey JB, et al. Persistence of Ebola virus in ocular fluid during convalescence. New England Journal of Medicine 2015; 372: 24232427.
18. Varkey JB, et al. Persistence of Ebola virus in ocular fluid during convalescence. New England Journal of Medicine 2015; 372: 2469.
19. Deen GF, et al. Ebola RNA persistence in semen of Ebola virus disease survivors – preliminary report. New England Journal of Medicine. Published online: 14 October 2015. doi:10.1056/NEJMoa1511410.
20. Formenty P, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clinical Infectious Diseases 2006; 42: 15211526.
21. MacIntyre CR, et al. Uncertainty, risk analysis and change for Ebola personal protective equipment guidelines. International Journal of Nursing Studies 2014; 5: 899903.
22. Towner JS, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. Journal of Virology 2004; 78: 43304341.
23. Johnson E, et al. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. International Journal of Experimental Pathology 1995; 76: 227236.
24. Farmer P. Re-infection after being PCR'd negative? 2014 (http://www.ebolainfo.org/reinfection-after-being-pcrd-negative_topic31097.html). Accessed 27 January 2015.
25. Kelly JD, Richardson ET, Barry M. Persistent Ebola virus in the eye. New England Journal of Medicine 2015; 373: 19811982.
26. Yeh S, Varkey JB, Crozier I. Persistent Ebola virus in the eye. New England Journal of Medicine 2015; 373: 19821983.
27. Martini GA, Schmidt HA. Spermatogenic transmission of the ‘Marburg virus’. Causes of Marburg simian disease [in German]. Klinische Wochenschrift 1968; 46: 398400.
28. Smith DH, et al. Marburg-virus disease in Kenya. Lancet 1982; 1: 816820.
29. Gear JS, et al. Outbreake of Marburg virus disease in Johannesburg. British Medical Journal 1975; 4: 489–93.
30. Leroy EM, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355: 22102215.
31. Heffernan RT, et al. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997. Journal of Infectious Diseases 2005; 191: 964968.
32. Deng IM, et al. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bulletin of the World Health Organization 1978; 56: 247270.
33. Gholipour B. U.S. Ebola survivors are likely now immune to virus strain, experts say 2014 (http://www.huffingtonpost.com/2014/08/25/ebola-survivors-immune_n_5711581.html). Accessed 27 January 2015.
34. Baschiera D. Ebola outbreak: Darwin volunteer writes from Sierra Leone treatment centre, ‘I just cry in my goggles’ 2014 (http://www.abc.net.au/news/2014-11-26/darwin-ebola-volunteer-dan-baschiera-writes-from-sierra-leone/5919516). Accessed 27 January 2015.
35. Qiu X, et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Scientific Reports 2013; 3: 3365.
36. Roels TH, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S9297.
37. Ksiazek TG, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S177187.
38. Fitzpatrick G, et al. The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins Sans Frontieres Ebola case management centre, Kailahun, Sierra Leone, June–October 2014. Journal of Infectious Diseases 2015; 212: 17.
39. Mackay IM, Arden KE. Ebola virus in the semen of convalescent men. Lancet Infectious Diseases 2014; 15: 149150.
40. World Health Organization (WHO). Ebola virus disease http://www.who.int/mediacentre/factsheets/fs103/en/. Accessed 29 January 2015.
41. World Health Organization (WHO). Frequently asked questions on Ebola virus disease (http://www.who.int/csr/disease/ebola/faq-ebola/en/). Accessed 2 January 2016.
42. Toweh A. Liberia urges sexual caution to beat Ebola outbreak. Reuters (http://www.reuters.com/article/2015/03/29/us-health-ebola-liberia-idUSKBN0MP0QM20150329). Accessed 1 April 2015.
43. Glaser E. Challenges in getting to zero, will abstinence be key? (http://www.ghdonline.org/ebola/discussion/challenges-in-getting-to-zero-will-abstinence-be-k/?id=17796018&format=html&type=instant). Accessed 1 April 2015.
44. Center for Disease Control and Prevention (CDC). Recommendations for breastfeeding/infant feeding in the context of Ebola (http://www.cdc.gov/vhf/ebola/hcp/recommendations-breastfeeding-infant-feeding-ebola.html). Accessed 10 February 2015.
45. Boyle D. Ebola nurse Pauline Cafferkey now critically ill 2015 (http://www.telegraph.co.uk/news/health/news/11931143/Ebola-nurse-Pauline-Cafferkey-is-now-critically-ill.html). Accessed 18 October 2015.
46. Franz DR, et al. Clinical recognition and management of patients exposed to biological warfare agents. Journal of the American Medical Association 1997; 278: 399411.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 28
Total number of PDF views: 254 *
Loading metrics...

Abstract views

Total abstract views: 468 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th November 2017. This data will be updated every 24 hours.